CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


<
Johnson & Johnson  (JNJ)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 



 

Johnson & Johnson

JNJ's Financial Statements and Analysis




Johnson & Johnson reported in II. Quarter net earnings per share of $1.40 a decrease by 0 % year on year from $1.43 and decline of 0 % from $1.61 earned in I. Quarter (Apr 02 2017).

Johnson & Johnson's Revenue rose by % in II. Quarter (Jul 02 2017) year on year, to $18,839 million and advanced by 6.04 % sequentially.


Johnson & Johnson is Expected to report next financial results on October 13, 2017.
More on JNJ's Income Statement

II. Quarter
Earnings Per Share Revenues
$ 1.4 $  18,839 Mill
$-0.03     -2.1 % $+357M     +1.93 %
You need to upgrade your Flash Player


       
  • PROCRIT 77.52% Y/Y,
• RISPERDAL 76.41% Y/Y,
• REMICADE 83.39% Y/Y,
• VELCADE 75.58% Y/Y,
• CONCERTA 218.52% Y/Y,
• INVEGA 105.77% Y/Y
   
     
       
  • Other -2.12% Y/Y,
• Total Pharmaceutical -4.35% Y/Y,
• Med. Dev. & Diag. -3.24% Y/Y,
• Nutritionals -4.42% Y/Y,
• Skin Care -2.83% Y/Y,
• Total Consumer -2.95% Y/Y
   
     


JNJ's Segments

JNJ's NET INCOME

Johnson & Johnson's net income of $3,827 million in II. Quarter decreased by -4.25 % from net earnings of $3,997 million achieved in II. Quarter a year ago.

Sequentially net earnings fell by -13.46 % from net income of $4,422.00 million realized in previous quarter.

More on JNJ's Growth

Johnson & Johnson Income Growth by Division

• Med. Dev. & Diag. -11.36% Y/Y • Total Pharmaceutical 39.91% Y/Y,
• Total Consumer 232.92% Y/Y

Inventories Inventories grew by 13.8 % to $9,699 million from II. Quarter a year ago, sequentially inventories rose by 9.25 %. In II. Quarter company's net cash and cash equivalents decreased by $-8,311 million, capital expenditures grew by -8.98%, to $-689 millions compare to same quarter a year ago and fell by 23.04% from I. Quarter (Apr 02 2017).

More on JNJ's Cash flow Statement



Johnson & Johnson payed out dividend of $3.24 per share in last 52 weeks representing 54.27 % of net earning per share in trailing twelve-month period.

During the same period Johnson & Johnson earned $ 7.35 cash per share, on a free-cash flow basis 123.12 % of net earning per share.

Book value grew by 2.73 % sequentially to $26.23 per share, 4.98% of net income per share in trailing twelve-month period were contributed to shareholder value.


Company repurchased 13.00 million shares or 0.47 % in II. Quarter.
Interest Coverage Ratio was 25.69. Debt Coverage Ratio was 0.69.

More on JNJ's Dividends
 Market Capitalization (Millions) 363,605
 Shares Outstanding (Millions) 2,742
 Total Debt (Millions $) 34,572
 Revenue (TTM) (Millions $) 72,531
 Net Income (TTM) (Millions $) 16,500
 Cash Flow (TTM) (Millions $) -6,042
 Capital Exp. (TTM) (Millions $) -3,079
 Dividend TTM ($) 3.24 $
 Dividend Yield TTM (%) 2.53 %
 Employees (TTM) $ 126,500


   

Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
RLOG's Profile
Stock Price
RLOG's Financials
RLOG's Expectations
Business Description
Fundamentals
Charts & Quotes
RLOG's News
Suppliers
RLOG's Competitors
Customers & Markets
Economic Indicators
RLOG's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com